15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Aveanna Healthcare Holdings Inc, 7 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $10.00 to $16.00, a moderate spread. The average target of $13.50 sits 1% below the current $13.65. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 5% this year and 6% next, consensus EPS building from about $0.21 next quarter toward $0.90 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Strong Buy
Strong Buy110%
Buy660%
Hold330%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Aveanna Healthcare Holdings Inc.
As of Sep, 7 of 9 firms rate AVAH a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AVAH EPS & revenue forecast
EPS · NEXT QUARTER
$0.21
Range $0.20 – $0.23 · 10 analysts · +26% YoY
Next period, 10 analysts expect Aveanna Healthcare Holdings Inc to earn $0.21 a share (range $0.20 – $0.23), versus $0.17 a year earlier. Full-year consensus is $0.82, growing to $0.90 the year after.
REVENUE · NEXT QUARTER
$694.3M
Range $683.0M – $715.5M · 10 analysts · +6% YoY
Revenue is expected to reach $694.3M (range $683.0M – $715.5M), +6.0% year-over-year. Full-year consensus is $2.7B, rising to $2.9B next year.
Top analysts covering Aveanna Healthcare Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AVAH.
#1
DM
David Macdonald
Truist Securities · Rank #109
Hold
$15.00+9.8% to target
Overall win rate
48%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #149
Buy
$16.00+17.2% to target
Overall win rate
44%
+ Follow
#3
Brian Tanquilut
Jefferies · Rank #208
Buy
$10.00-26.8% to target
Overall win rate
42%
+ Follow
#4
AR
A.J. Rice
UBS
Hold
$13.00-4.8% to target
Coverage
—
+ Follow
#5
Andrew Mok
Barclays
Buy
$15.00+9.8% to target
Coverage
—
+ Follow
AVAH stock forecast FAQ
What is AVAH's average 12-month price target?+
The 9 analysts with a live target average $13.50 for Aveanna Healthcare Holdings Inc over the next 12 months, ranging from a $16.00 high to a $10.00 low.
Is AVAH stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 10 analyst ratings, 7 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AVAH?+
The Street-high target is $16.00 (RBC Capital), and the Street-low is $10.00 (JP Morgan). The average of all 9 active targets is $13.50.
How many Wall Street analysts cover AVAH?+
10 analysts have an active rating on Aveanna Healthcare Holdings Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering AVAH?+
Among analysts who currently cover AVAH, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #109). Their current call is Hold with a $15.00 target.
What is Aveanna Healthcare Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $0.21 per share (range $0.20 – $0.23) across 10 analysts. Full-year EPS is projected at $0.82, rising to $0.90 the following year.
How much revenue is Aveanna Healthcare Holdings Inc expected to report next quarter?+
Consensus revenue is $694.3M (range $683.0M – $715.5M). Full-year revenue is projected at $2.7B, growing to $2.9B next year.
Have analysts been upgrading or downgrading AVAH lately?+
As of Sep, 7 of 9 firms rate AVAH a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AVAH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
